FDA names new No. 2 to re­place re­tir­ing Sher­man

The US Food and Drug Ad­min­is­tra­tion (FDA) an­nounced Mon­day that Dr. Amy Aber­nethy will re­place Rachel Sher­man as Prin­ci­pal Deputy com­mis­sion­er of Food and Drugs – the high­est po­si­tion at the agency that is not a po­lit­i­cal ap­pointee.

Aber­nethy is the for­mer chief med­ical of­fi­cer, chief sci­en­tif­ic of­fi­cer and se­nior vice pres­i­dent, on­col­o­gy, at Flat­iron Health, which is a unit of Roche. Pri­or to that she was a pro­fes­sor of med­i­cine at Duke Uni­ver­si­ty School of Med­i­cine and ran the Cen­ter for Learn­ing Health Care in the Duke Clin­i­cal Re­search In­sti­tute and Duke Can­cer Care Re­search Pro­gram in the Duke Can­cer In­sti­tute.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER